How CTMC And KSQ's Partnership Is Accelerating TIL Research
Source: Bioprocess Online
CTMC can be described as a boutique CDMO, but their relationship with KSQ is a true partnership that leverages MD Anderson’s experience with oncology research to take TIL therapies to the next level.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
This website uses cookies to ensure you get the best experience on our website. Learn more